Global pharmaceutical giant Lupin Limited (Lupin), following Lupin's alliance partner Caplin Steriles Limited, has launched 50mg/5mL (10mg/mL) and 100mg/10mL (10mg/mL) multi-dose rocuronium bromide injection vials. Announced the release of. (Caplin) received approval for his ANDA from the U.S.
Food and Drug Administration (FDA).Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL) and 100 mg/10 mL (10 mg/mL) multi-dose vials are available as Zemron Injection, 50 mg/5 mL and 100 mg/10 this is a generic version. Ml is marketed by Organon USA Inc. and is used as an adjunct to general anesthesia in the hospital to facilitate both rapid and
routine end tracheal intubation and to ensure relaxation of skeletal muscles during surgery or mechanical ventilation. Indicated for patients and outpatients. Rocuronium Bromide Injection (Zemuron) had estimated annual sales of $54 million in the United States (IQVIA MAT, August 2023).Lupine is an innovation-driven
multinational pharmaceutical company headquartered in Mumbai, India. The company develops and markets a wide range of branded and generic formulations, biotechnology products and APIs in more than 100 markets, including the United States, India and South Africa, as well as Asia Pacific (APAC), Latin America (LATAM) and Europe. Masu. Middle East region.Lupine's journey is a testament to the potential of human imagination, compassion, and the unwavering pursuit of a better future. Lupine was founded in 1968 by its visionary founder, Dr. Lupine. Desh Bandhu Gupta rose from humble beginnings to become a
global healthcare leader . Headquartered in Mumbai, India, we have an expanded presence in the United States, Latin America, APAC, and EMEA, with operations in more than 100 countries and a diverse portfolio of more than 1,000 products.
, CDSCO.jpg)
.jpg)